Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History HROW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics HROW

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Harrow Health Inc

HROW
Current price
35.89 USD -0.33 USD (-0.91%)
Last closed 34.55 USD
ISIN US4158581094
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 151 266 432 USD
Yield for 12 month +43.50 %
1Y
3Y
5Y
10Y
15Y
HROW
21.11.2021 - 28.11.2021

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee. Address: 1A Burton Hills Boulevard, Nashville, TN, United States, 37215

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

56.89 USD

P/E Ratio

Dividend Yield

Financials HROW

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures HROW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+199 614 000 USD

Last Year

+130 193 000 USD

Current Quarter

+47 831 000 USD

Last Quarter

+66 831 000 USD

Current Year

+150 369 000 USD

Last Year

+90 553 000 USD

Current Quarter

+32 307 000 USD

Last Quarter

+52 696 000 USD
EBITDA 19 511 000 USD
Operating Margin TTM -23.48 %
Price to Earnings
Return On Assets TTM 0.90 %
PEG Ratio
Return On Equity TTM -37.31 %
Wall Street Target Price 56.89 USD
Revenue TTM 212 858 000 USD
Book Value 1.58 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 38.30 %
Dividend Yield
Gross Profit TTM 158 642 000 USD
Earnings per share -0.61 USD
Diluted Eps TTM -0.61 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -64.00 %
Profit Margin -10.19 %

Stock Valuation HROW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 126.58
Enterprise Value Revenue 6.23
Price Sales TTM 5.41
Enterprise Value EBITDA 71.06
Price Book MRQ 20.58

Technical Indicators HROW

For 52 Weeks

20.85 USD 59.23 USD
50 Day MA 28.55 USD
Shares Short Prior Month 4 064 795
200 Day MA 34.13 USD
Short Ratio 9.05
Shares Short 4 134 851
Short Percent 14.00 %